Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ATRA

Atara Biotherapeutics Inc

Jun 09 • 04:00PM ET

9.77

+0.19 1.98 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: CLLS FATE ALLO CHRS ALEC ZNTL CCCC REPL ELDN LENZ

| Held by: VTI VXF IWC DCOR DFAC BTEC DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.88	Insider Own	34.02%	Shs Outstand	8.51M	Perf Week	-1.31%
Market Cap	88.03M	Forward P/E	10.92	EPS next Y	0.90	Insider Trans	3.40%	Shs Float	5.95M	Perf Month	17.15%
Enterprise Value	131.23M	PEG	-	EPS next Q	-0.32	Inst Own	48.40%	Short Float	8.14%	Perf Quarter	55.33%
Income	-9.47M	P/S	3.80	EPS this Y	-150.39%	Inst Trans	1.01%	Short Ratio	0.34	Perf Half Y	-31.82%
Sales	23.14M	P/B	-	EPS next Y	169.11%	ROA	-23.08%	Short Interest	0.48M	Perf YTD	-45.99%
Book/sh	-4.38	P/C	10.53	EPS next 5Y	-	ROE	-	52W High	19.15 -48.97%	Perf Year	5.56%
Cash/sh	0.93	P/FCF	-	EPS past 3/5Y	- -	ROIC	-75.60%	52W Low	3.92 149.23%	Perf 3Y	-80.26%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	23.85% -	Gross Margin	96.12%	Volatility	7.38% 10.35%	Perf 5Y	-97.26%
Dividend TTM	-	EV/Sales	5.67	EPS Y/Y TTM	76.14%	Oper. Margin	-26.42%	ATR (14)	0.89	Perf 10Y	-98.06%
Dividend Ex-Date	-	Quick Ratio	2.16	Sales Y/Y TTM	-88.41%	Profit Margin	-40.91%	RSI (14)	56.61	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	2.16	EPS Q/Q	-108.40%	SMA20	-1.25%	Beta	0.12	Target Price	13.67
Payout	0.00%	Debt/Eq	-	Sales Q/Q	-99.47%	SMA50	36.51%	Rel Volume	0.05	Prev Close	9.58
Employees	14	LT Debt/Eq	-	Earnings	May 12 AMC	SMA200	-3.06%	Avg Volume	1.41M	Price	9.77
IPO	Oct 16, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	11.99% -82.21%	Trades		Volume	65,930	Change	1.98%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)